🇺🇸 FDA
Pipeline program

Lifileucel (LN-144/LN-145)

22-109

Phase 1 mab active

Quick answer

Lifileucel (LN-144/LN-145) for Uveal Melanoma is a Phase 1 program (mab) at IOVANCE BIOTHERAPEUTICS, INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
IOVANCE BIOTHERAPEUTICS, INC.
Indication
Uveal Melanoma
Phase
Phase 1
Modality
mab
Status
active

Clinical trials